胎儿神经超声检查可作为诊断结节性硬化症脑部受累的准确工具
这项多中心回顾性研究纳入20例结节性硬化症高危胎儿,评估专用神经超声对脑部受累的诊断价值;15例存在脑部受累,专用神经超声似有效,作者建议作为一线方法;在已有超声发现时MRI附加价值似乎较低。
要点
- 20例高危胎儿中15例存在结节性硬化症相关脑部受累。
- 作者认为专用神经超声对诊断结节性硬化症高危胎儿的脑部受累似乎有效,建议作为一线方法。
- 在已有超声发现时,MRI的附加价值似乎较低(行MRI病例数少)。
核心结论
- 与现有文献相反,专用神经超声似乎能有效诊断结节性硬化症高危胎儿的脑部受累,应作为一线方法。
- 尽管行MRI的病例数少,但在有超声发现时,MRI的附加价值似乎较低。
研究设计与样本
- 多中心回顾性研究,纳入20例结节性硬化症高危胎儿,复习专用神经超声、胎儿磁共振成像(MRI)及出生后报告。
主要发现
- 19例因心脏横纹肌瘤转诊,1例因涉及结节性硬化症基因座的16号染色体缺失转诊。
- 心脏横纹肌瘤诊断的平均孕龄为27+2周(范围16+0至36+3周),每例患者心脏横纹肌瘤平均数量为4个(范围1-10个)。
- 15例胎儿存在脑部受累,其中13例通过以下一种或多种方式确诊:染色体微阵列分析(n=1)、外显子组测序(n=7)、尸检(n=4)、新生儿临床结节性硬化症(n=4)及同胞确诊临床结节性硬化症(n=1)。
- 2例脑部受累者疾病未能确认:1例失访,另1例终止妊娠后未行尸检。
- 无脑部发现的5例中,3例通过外显子组测序(n=2)和/或尸检发现(n=2)确诊结节性硬化症;其余2例外显子组测序正常,其中1例有5个心脏横纹肌瘤(高度提示性发现),最后1例尸检正常,为本队列唯一假阳性病例。
临床怎么用
- 作者认为专用神经超声应作为结节性硬化症高危胎儿诊断脑部受累的一线方法。
- 作者认为在已有超声发现时,MRI的附加价值似乎较低。
局限性
- 行MRI的病例数少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To demonstrate the potential utility of dedicated neurosonography for the diagnosis of fetal brain involvement in tuberous sclerosis complex. METHODS: This was a multicenter retrospective study of fetuses at high risk for tuberous sclerosis complex. Dedicated neurosonographic, fetal magnetic resonance imaging (MRI) and postnatal reports were reviewed. Data collected included reason for referral, gestational age at which cardiac rhabdomyoma was first suspected and final number of cardiac rhabdomyomas detected on dedicated imaging. We searched for tuberous sclerosis complex-related brain involvement, defined as the presence of one or more of the following findings: white-matter lesions; subependymal nodules; cortical/subcortical tubers; and subependymal giant-cell astrocytoma. RESULTS: We included 20 patients at high risk of tuberous sclerosis complex, of whom 19 were referred for the presence of cardiac rhabdomyomas and one for a deletion in chromosome 16 involving the tuberous sclerosis complex gene locus. Cardiac rhabdomyomas were diagnosed at a mean gestational age of 27 + 2 weeks (range, 16 + 0 to 36 + 3 weeks) and the mean number of cardiac rhabdomyomas per patient was 4 (range, 1-10). Brain involvement was present in 15 fetuses, in 13 of which the disease was confirmed in one or more of the following ways: chromosomal microarray analysis (n = 1), exome sequencing (n = 7), autopsy (n = 4), clinical tuberous sclerosis complex in the newborn (n = 4) and a sibling diagnosed with clinical tuberous sclerosis complex (n = 1). In two cases, the disease could not be confirmed: one was lost to follow-up and autopsy, following termination of pregnancy, was not performed in the other. Among the five cases without brain findings, tuberous sclerosis complex was confirmed in three by exome sequencing (n = 2) and/or autopsy findings (n = 2). The two remaining cases had normal exome sequencing; one case had five cardiac rhabdomyomas, which was a highly suggestive finding, while in the final case, the autopsy was considered normal, representing the only false-positive case in our cohort. CONCLUSIONS: Contrary to current literature, dedicated neurosonography appears to be effective in the diagnosis of brain involvement in fetuses at risk of tuberous sclerosis complex and should be used as the first-line approach. Although the number of cases in which MRI was performed was small, it seems that, in the presence of ultrasound findings, the added value of MRI is low. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Malinger G, Prabhu A, Maroto González A, et al. Fetal neurosonography as accurate tool for diagnosis of brain involvement in tuberous sclerosis. Ultrasound Obstet Gynecol. 2023. PMID: 37021742. doi:10.1002/uog.26213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。